Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Payers
CVS hit with lawsuit over dropping Zepbound from formulary
A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound.
Paige Minemyer
Sep 5, 2025 4:58pm
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
Aug 4, 2025 2:50pm
Hims & Hers to offer generic semaglutide drugs in Canada
Jul 11, 2025 3:30pm
WeightWatchers inks deal with Novo Nordisk to sell Wegovy
Jun 26, 2025 3:30pm
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Jun 23, 2025 12:00pm
Novo Nordisk taps Hims & Hers, LifeMD and Ro for GLP-1 tie-up
Apr 29, 2025 5:15pm
